Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center

• Published in: Journal of psoriasis and psoriatic arthritis Vol. 8; no. 4; pp. 134 - 140
• Main Authors: Haberman, Rebecca H., Um, Seungha, Catron, Sydney, Chen, Alan, Lydon, Eileen, Attur, Malavikalakshmi, Neimann, Andrea L., Reddy, Soumya, Troxel, Andrea, Adhikari, Samrachana, Scher, Jose U.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.10.2023
• Subjects: treatment outcomes < treatment < psoriasis; patient-reported outcome < psoriasis; depression < comorbidity < psoriasis; psoriatic arthritis; psoriasis; psoriatic arthritis, depression, pain; pain; depression
• ISSN: 2475-5303; 2475-5311
• DOI: 10.1177/24755303231186405

Backgroud Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that, when left untreated, can lead to erosions, deformities and decrease in quality of life. PsA is known to be associated with multiple comorbidities, including cardiovascular, metabolic and mental health syndromes, all of which can increase its overall morbidity and mortality. Objective To characterize a cohort of patients with PsA and understand the impact of depression on PsA outcome measures. Methods 527 consecutive patients with PsA were enrolled in an observational, longitudinal registry that followed them prospectively at standard of care visits. Demographics, medical history, medication use, and clinical exam were all recorded. Results Depression was reported in 22.8% of the population, anxiety in 18%, and attention deficit hyperactivity disorder in 4%. Depression was more common in female participants (P < .001). At baseline, individuals with PsA and concomitant depression had similar tender and swollen joint counts and RAPID3 compared to those without depression, and had lower body surface area affected by psoriasis (P = .04). At year one, all patients had improvement in clinical outcomes. However, patients with depression had a significantly higher tender joint count compared to those without depression (P = .001), despite similar swollen joint count and body surface area. Conclusion In patients with depression, there is a discrepancy between improvement in physician assessed measures and patient reported outcomes. These observations underscore the importance of addressing depression and psychological distress as part of PsA treatment outcomes and points towards the need to address residual pain through co-adjuvant approaches.